Make Money, Make Time

Make Money, Make Time

5 Charts For The Week

Oliver | MMMT Wealth's avatar
Oliver | MMMT Wealth
Oct 27, 2025
āˆ™ Paid
19
3
Share

Hi allšŸ‘‹

Make Money, Make Time is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Choppy week last week that eventually ended up in the green. Green weeks are obviously great, but they ultimately present less opportunities for us in the markets.

There’s still a good portion of my portfolio that I would happily add to at today’s prices, but unfortunately we don’t have an infinite amount of cash at our disposal so being very picky with buys today is encouraged. I do believe we will get opportunities to deploy more cash sooner rather than later, but until then I am adding small to some positions, making some small trims in others, and trying to find some other undervalued plays that haven’t moved +100% already this year.

Here’s 5šŸ‘‡


1. CryoPort | CYRX

CYRX isn’t the type of company I tend to look into much. Mainly because:

  • FCF is so volatile

  • EBITDA multiple is 63x

But ever since Trump mentioned he wanted to increase the accessibility of IVF and other fertility treatments, I wanted to consider getting some exposure to this theme and I think CYRX is potentially one of the strongest in the market to do this.

From a technical standpoint, it’s finally above a key support level, above the 200MA and broke the downward trend they were in. From a more fundamental point of view, net cash makes up ~2/5th of the market cap which for companies in this niche is very good. This is one of those catalyst driven stocks that can easily have +20% days on some good news. I think it’s potentially worth exposing yourself to this theme.


2. Harrow | HROW

As paid subs will know, HROW is a well-sized position in my portfolio. If you want to know why, read my thesis here:

Harrow (HROW): High Growth Outside Tech

Harrow (HROW): High Growth Outside Tech

Oliver | MMMT Wealth
Ā·
Sep 24
Read full story

76% estimated EBITDA growth whilst trading below 17x NTM EBITDA. There’s really not many stocks out there trading that cheaply today.


3. Draganfly | DPRO

I’m very torn on DPRO for 2 reasons:

  1. It’s cheap. In fact it’s one of the more attractive positions in my ā€œInvesting Universeā€ (paid subs). You’ve got a company growing an estimated +130% between 2025 and 2026 for just 17x sales. That’s quite cheap.

  2. But fundamentally I struggle. I don’t see much room for margin expansion over the next 2-3 years and I think competition in the drone market will be very challenging.

If I did invest in DPRO, it would be purely from a technical basis and the chart looks nice, but I’d never make it a larger position so that’s it’s a core part of my portfolio.


Keep reading with a 7-day free trial

Subscribe to Make Money, Make Time to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
Ā© 2025 Oliver Cull
Privacy āˆ™ Terms āˆ™ Collection notice
Start your SubstackGet the app
Substack is the home for great culture